Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$2.09

Avg closing price
Price range

24 Jim Simons CTI BioPharma Trades

The first CTI BioPharma trade was made in Q1 2017. Since then Jim Simons bought shares fourteen more times and sold shares on nine occasions. The investor completely sold their stake between Q3 2021 and Q4 2022.

Avg closing price
Price range
Sold -26.5 Thousand shares Q4 2022
Avg closing price $5.46
Price range $4.45 - $6.17
Sold 94.0% shares (-417 Thousand shares) Q3 2022
Avg closing price $6.23
Price range $5.36 - $7.43
Sold 60.1% shares (-668 Thousand shares) Q2 2022
Avg closing price $5.12
Price range $3.55 - $6.27
Sold 18.0% shares (-244 Thousand shares) Q1 2022
Avg closing price $2.98
Price range $1.90 - $5.23
Sold 24.3% shares (-434 Thousand shares) Q4 2021
Avg closing price $2.45
Price range $1.44 - $2.86
Sold 26.6% shares (-649 Thousand shares) Q3 2021
Avg closing price $2.72
Price range $2.25 - $3.18
Increased shares by 51.4% (+828 Thousand shares) Q2 2021
Avg closing price $2.40
Price range $2.16 - $2.62
Sold 10.5% shares (-188 Thousand shares) Q1 2021
Avg closing price $3.26
Price range $2.68 - $3.80
Sold 18.1% shares (-396 Thousand shares) Q4 2020
Avg closing price $3.33
Price range $2.48 - $3.80
Increased shares by 4.4% (+91.8 Thousand shares) Q3 2020
Avg closing price $1.28
Price range $1.02 - $2.15
Increased shares by 0.8% (+17.7 Thousand shares) Q2 2020
Avg closing price $1.06
Price range $0.88 - $1.32
Increased shares by 6.0% (+118 Thousand shares) Q1 2020
Avg closing price $1.15
Price range $0.69 - $1.54
Increased shares by 4.8% (+90 Thousand shares) Q4 2019
Avg closing price $0.95
Price range $0.72 - $1.64
Increased shares by 17.6% (+281 Thousand shares) Q3 2019
Avg closing price $0.76
Price range $0.64 - $0.92
Increased shares by 24.5% (+314 Thousand shares) Q2 2019
Avg closing price $0.92
Price range $0.80 - $1.03
Increased shares by 17.9% (+195 Thousand shares) Q1 2019
Avg closing price $1.05
Price range $0.90 - $1.37
Increased shares by 42.8% (+326 Thousand shares) Q4 2018
Avg closing price $1.64
Price range $0.73 - $2.19
Sold 1.5% shares (-11.9 Thousand shares) Q3 2018
Avg closing price $2.48
Price range $1.72 - $5.24
Increased shares by 12.3% (+84.5 Thousand shares) Q2 2018
Avg closing price $4.38
Price range $3.81 - $5.26
Increased shares by 13.0% (+79.1 Thousand shares) Q1 2018
Avg closing price $3.52
Price range $2.70 - $4.06

News about CTI BioPharma Corp and Jim Simons

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!